Selumetinib in Children with Inoperable Plexiform Neurofibromas
Author(s) -
Andrea M. Gross,
Pamela L. Wolters,
Eva Dombi,
Andrea Baldwin,
Patricia Whitcomb,
Michael J. Fisher,
Brian Weiss,
AeRang Kim,
Miriam Bornhorst,
Amish C. Shah,
Staci Martin,
Marie Claire Roderick,
Dominique C. Pichard,
Amanda Carbonell,
Scott M. Paul,
Janet Therrien,
Oxana B. Kapustina,
Kara Heisey,
D. Wade Clapp,
Chi Zhang,
Cody J. Peer,
William D. Figg,
Malcolm A. Smith,
John Glod,
Jaishri O. Blakeley,
Seth M. Steinberg,
David Venzon,
L. Austin Doyle,
Brigitte C. Widemann
Publication year - 2020
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1912735
Subject(s) - plexiform neurofibroma , neurofibromatosis , selumetinib , medicine , neurofibroma , radiology , cancer , colorectal cancer , kras
No approved therapies exist for inoperable plexiform neurofibromas in patients with neurofibromatosis type 1.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom